Dublin, Sept. 26, 2017 -- The "Global Industrial Microbiology Market - Analysis and Forecast (2017-2025) (Focus on Competitive Landscape, Market Dynamics, Country Analysis, End Users, Application, and Patent Landscape)" report has been added to Research and Markets' offering.
The global industrial microbiology market accounted for $2.3 billion revenue in 2016
Several factors such as increase in significance of industrial food and safety, growing awareness among researchers about new strains of microorganisms, increase in preference for consumer products such as OTC drugs, food items and packaged water, growing demand of pathogen testing in food products, increasing automation in products, growing research initiatives in different fields of industrial microbiology and rising number of collaborations among companies are driving the growth of industrial microbiology market.
There are certain potential factors providing tremendous opportunities for several companies worldwide to grow, sustain and generate revenue in the field of industrial microbiology. Such factors are growing use of generics and OTC drugs by consumers that is providing an excellent opportunity for pharmaceutical and biotechnology companies to develop cost effective therapies.
Increase in usage of microorganisms for syrup formulations, genetically modified food products, empty capsules as well as bioremediation process is also providing promising opportunities for this market to grow in coming years. Emergence of automated products, use of biocides and microbicides for water treatment, environmental monitoring, and rapid sterility testing methods, among others are driving factors for the growth of the industrial microbiology market.
Key Topics Covered:
Executive Summary
1 Report Scope and Methodology
1.1. Scope of the Report
1.2. Global Industrial Microbiology Market Segmentation
1.3 Key Learnings
1.4 Research Methodology
2 Market Overview
3 Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
4 Competitive Landscape
4.1. Key Development and Strategies
4.1.1 Mergers & Acquisition
4.1.2 New Product Launches and Developments
4.1.3 Collaborations, Joint Ventures and Partnerships
4.1.4 Accreditations and Certifications
4.1.5 Others
4.2. Research and Development (R&D) Analysis
5 Industry Insights
5.1 Consortium, Association, and Regulatory Bodies
5.2. Patent Landscape
6 Global Industrial Microbiology Market, by Product
6.1. Overview
6.2 Media
6.3 Blood and Sera
6.4 Reagents and Supplements
6.5 Rapid Detection Kits Assays
6.6 Instruments
6.7 Plastic and Glassware
6.8 Others
7 Global Industrial Microbiology Market, by Application
7.1. Overview
7.2. Food
7.3. Environmental and Waste Management
7.4. Biopharmaceutical
7.5. cosmetic
7.6 Others
8 Global Industrial Microbiology Market, by End User
8.1. Overview
8.2. Biopharmaceutical
8.3. Commercial Quality Assurance
8.4 Research Institution
8.5 Industrial
8.6 Regulatory Bodies
8.7 Others
9 Global Industrial Microbiology Market, by Geography
9.1. Overview
9.2. North America
9.3. Europe
9.4. Asia-Pacific
9.5. Latin America
9.6. Rest of the World
10 Company Profiles
10.1. 3M
10.2. Axon Lab AG
10.3. Becton Dickinson and Company
10.4. Bio-Rad Laboratories Inc.
10.5. bioMrieux SA
10.6. Danaher Corporation
10.7. Eppendorf AG
10.8. HiMedia Laboratories
10.9 Hy Laboratories Ltd
10.10 Merck KGaA
10.11 Novamed
10.12 QIAGEN
10.13 Sartorius AG
10.14 Solenis
10.15 Thermo Fisher Scientific Inc
For more information about this report visit https://www.researchandmarkets.com/research/tkdwb9/global_industrial
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology


South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 



